Acceptance and Commitment Therapy for Depression

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
University of Alabama at Birmingham, Birmingham, AL
Depression+1 More
Acceptance and commitment therapy - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The purpose of the pilot study is to assess the effects of an 8-week program on improving mental health in depressed family caregivers of people with dementia. The program will involve 8 weekly coach-guided videoconferencing sessions and the use of a web app based on acceptance and commitment therapy (ACT) for 8 weeks. Also, the study aims to understand these caregivers' experiences in the program, including their perspectives on the app features and contents. We aim to recruit 8-10 people for this pilot project. Outcomes regarding caregivers' mental health and ACT processes will be collected at pretest and posttest (after the completion of the 8-week program) and compared over time (i.e., posttest scores compared to pretest). At posttest, acceptability and perceived usability of the app will be evaluated using the 10-item System Usability Scale and 30-40 minute individual interviews.

Eligible Conditions

  • Depression

Treatment Effectiveness

Study Objectives

1 Primary · 11 Secondary · Reporting Duration: immediately after the 8-week intervention

Change from baseline to immediately after the 8-week intervention
Change from baseline to immediately after the 8-week intervention on the Action and Acceptance Questionnaire-II
Change from baseline to immediately after the 8-week intervention on the Caregiver Guilt Questionnaire
Change from baseline to immediately after the 8-week intervention on the Cognitive Fusion Questionnaire
Change from baseline to immediately after the 8-week intervention on the Engaged Living Scale
Change from baseline to immediately after the 8-week intervention on the Five Facet Mindfulness Questionnaire
Change from baseline to immediately after the 8-week intervention on the Generalized Anxiety Disorder-7
Change from baseline to immediately after the 8-week intervention on the Marwit-Meuser Caregiver Grief Inventory Brief-Form
Change from baseline to immediately after the 8-week intervention on the Patient Health Questionnaire-9
Change from baseline to immediately after the 8-week intervention on the Perceived Stress Scale
Change from baseline to immediately after the 8-week intervention on the Self-Compassion Scale-Short Form
Change from baseline to immediately after the 8-week intervention on the World Health Organization Quality of Life - Psychological health component
Change from baseline to immediately after the 8-week intervention on the Zarit Burden Interview
immediately after the 8-week intervention
System Usability Scale

Trial Safety

Trial Design

1 Treatment Group

Acceptance and Commitment Therapy
1 of 1
Experimental Treatment

10 Total Participants · 1 Treatment Group

Primary Treatment: Acceptance and Commitment Therapy · No Placebo Group · N/A

Acceptance and Commitment Therapy
Behavioral
Experimental Group · 1 Intervention: Acceptance and commitment therapy · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: immediately after the 8-week intervention

Trial Background

Prof. Areum Han, Assistant professor
Principal Investigator
University of Alabama at Birmingham
Closest Location: University of Alabama at Birmingham · Birmingham, AL
Photo of university of alabama at birmingham  1Photo of university of alabama at birmingham  2Photo of university of alabama at birmingham  3
1991First Recorded Clinical Trial
22 TrialsResearching Depression
1066 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have at least mild depression as measured by the PHQ-9.
You have a web-enabled device with internet access at home.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.